APA (7th ed.) Citation

JKK, M., AH, T., & BK, Y. (2025). Epstein-Barr virus-infected nasopharyngeal carcinoma therapeutics: Oncoprotein targets and clinical implications. Medical oncology (Northwood, London, England), 42(3), 59. https://doi.org/10.1007/s12032-025-02610-x

Chicago Style (17th ed.) Citation

JKK, Mark, Teh AH, and Yap BK. "Epstein-Barr Virus-infected Nasopharyngeal Carcinoma Therapeutics: Oncoprotein Targets and Clinical Implications." Medical Oncology (Northwood, London, England) 42, no. 3 (2025): 59. https://doi.org/10.1007/s12032-025-02610-x.

MLA (9th ed.) Citation

JKK, Mark, et al. "Epstein-Barr Virus-infected Nasopharyngeal Carcinoma Therapeutics: Oncoprotein Targets and Clinical Implications." Medical Oncology (Northwood, London, England), vol. 42, no. 3, 2025, p. 59, https://doi.org/10.1007/s12032-025-02610-x.